Dysregulation of the EphrinB2−EphB4 ratio in pediatric cerebral arteriovenous malformations is associated with endothelial cell dysfunction in vitro and functions as a novel noninvasive biomarker in patients
出版年份 2020 全文链接
标题
Dysregulation of the EphrinB2−EphB4 ratio in pediatric cerebral arteriovenous malformations is associated with endothelial cell dysfunction in vitro and functions as a novel noninvasive biomarker in patients
作者
关键词
-
出版物
EXPERIMENTAL AND MOLECULAR MEDICINE
Volume 52, Issue 4, Pages 658-671
出版商
Springer Science and Business Media LLC
发表日期
2020-04-14
DOI
10.1038/s12276-020-0414-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain
- (2018) Sergey I. Nikolaev et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutations in Chromatin Modifier and Ephrin Signaling Genes in Vein of Galen Malformation
- (2018) Daniel Duran et al. NEURON
- Using urinary bFGF and TIMP3 levels to predict the presence of juvenile pilocytic astrocytoma and establish a distinct biomarker signature
- (2016) Katie Pricola Fehnel et al. Journal of Neurosurgery-Pediatrics
- Soluble VE-cadherin is involved in endothelial barrier breakdown in systemic inflammation and sepsis
- (2015) S. Flemming et al. CARDIOVASCULAR RESEARCH
- The endogenous zinc finger transcription factor, ZNF24, modulates the angiogenic potential of human microvascular endothelial cells
- (2015) Di Jia et al. FASEB JOURNAL
- Netrin-1 Promotes Medulloblastoma Cell Invasiveness and Angiogenesis, and Demonstrates Elevated Expression in Tumor Tissue and Urine of Patients with Pediatric Medulloblastoma
- (2014) T. Akino et al. CANCER RESEARCH
- Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation
- (2014) Jie Bai et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Glucose Transporter 1-Positive Endothelial Cells in Infantile Hemangioma Exhibit Features of Facultative Stem Cells
- (2014) Lan Huang et al. STEM CELLS
- EndMT contributes to the onset and progression of cerebral cavernous malformations
- (2013) Luigi Maddaluno et al. NATURE
- Blocking ephrinB2 with highly specific antibodies inhibits angiogenesis, lymphangiogenesis, and tumor growth
- (2012) M. A. Abengozar et al. BLOOD
- Netrin-1 Promotes Glioblastoma Cell Invasiveness and Angiogenesis by Multiple Pathways Including Activation of RhoA, Cathepsin B, and cAMP-response Element-binding Protein
- (2012) Akio Shimizu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Thrombospondin-1 Modulates the Angiogenic Phenotype of Human Cerebral Arteriovenous Malformation Endothelial Cells
- (2011) Christopher J Stapleton et al. NEUROSURGERY
- The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis
- (2010) Georg Martiny-Baron et al. ANGIOGENESIS
- A semi-quantitative assay to screen for angiogenic compounds and compounds with angiogenic potential using the EA.hy926 endothelial cell line
- (2009) EVELYN ARANDA et al. BIOLOGICAL RESEARCH
- EPHB4 Gene Polymorphisms and Risk of Intracranial Hemorrhage in Patients With Brain Arteriovenous Malformations
- (2009) Shantel Weinsheimer et al. Circulation-Cardiovascular Genetics
- ABERRANT ANGIOGENIC CHARACTERISTICS OF HUMAN BRAIN ARTERIOVENOUS MALFORMATION ENDOTHELIAL CELLS
- (2009) Mark N. Jabbour et al. NEUROSURGERY
- Role of ephrinB2 expression in endothelial cells during arteriogenesis: impact on smooth muscle cell migration and monocyte recruitment
- (2008) T. Korff et al. BLOOD
- Urinary Biomarkers Predict Brain Tumor Presence and Response to Therapy
- (2008) E. R. Smith et al. CLINICAL CANCER RESEARCH
- Outcome after interventional or conservative management of unruptured brain arteriovenous malformations: a prospective, population-based cohort study
- (2008) Catherine J Wedderburn et al. LANCET NEUROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started